Vericel manufactures advanced cell therapies for the sports medicine and severe burn care markets. The goal of our therapies is to repair or restore a patient’s damaged tissues or organs using their own cells. Please use the links to the right to visit our product websites.

NASDAQ: VCEL

$11.07 0.67 (6.44%)
Day High: $11.35
Day Low: $10.56
Volume: 730173
4:00 PM on
April 9, 2020
Copyright West LLC. Minimum 15 minutes delayed.

Company Presentation